Statin

Quick links to important sections

Statin

Treatment option: Infection, Oral Cavity

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Statin

Property Description
Active ingredient Nystatin
Form Tablet, Suspension, Cream, Ointment, Powder
Pharmacological class Antifungal / Polyene Macrolide Antibiotic
Common use Localized fungal infections (e.g., candidiasis)
Origin Natural (Biosynthesized from Streptomyces noursei)

The medication identified by the composition Nystatin is a highly specialized antifungal agent, officially classified as a polyene macrolide antibiotic. It is essential to understand that Nystatin is chemically and functionally distinct from the cholesterol-lowering medicines frequently called "statins" (HMG-CoA reductase inhibitors), possessing no regulatory function concerning blood lipids. This fundamental pharmacological distinction confirms its exclusive therapeutic scope against fungal pathogens.


What Type of Medicine is Nystatin?

Nystatin is classified as an antimycotic agent that is naturally produced, specifically originating as a biosynthesized compound from the bacterium Streptomyces noursei. This classification places Nystatin within the group of medicines designed to combat yeasts and fungi. Nystatin demonstrates efficacy and specific action against Candida species, highlighting its utility in treating mucocutaneous infections. Its targeted nature is a clinically recognized initial treatment for common yeast overgrowth.


Composition and Available Forms of Nystatin

The medicine is defined as a single-ingredient product, containing only Nystatin as the active chemical substance. Nystatin is manufactured in multiple dosage form(s) to support localized administration, including oral tablets and suspension for internal mucosal or gastrointestinal application, as well as topical preparations such as creams, ointments, and powders. The designated route of administration relies on Nystatin’s characteristic of being poorly absorbed into the systemic circulation. This property means the medication’s activity is concentrated at the application site, supporting its unique role in local infection control.


Nystatin's General Purpose as a Local Antifungal

The general purpose of Nystatin is the reliable control and elimination of superficial or localized infections caused by yeasts, predominantly Candida species. A typical use scenario involves treating oral thrush. This benefit is achieved through its mechanism of targeting the ergosterol in the fungal cell membrane, which causes the fungal cell to break down. Due to its minimal systemic absorption, the drug's therapeutic goal is strictly to clear fungal overgrowth from surfaces like the mouth, skin, or lining of the digestive tract, positioning it as a primary treatment for localized candidiasis rather than systemic infections.

What side effects are possible with Statin?

Possible Side Effects and Safety Information

The safety profile of Nystatin, an antifungal agent with minimal systemic absorption, is characterized predominantly by localized reactions at the site of administration. Regulatory documents classify adverse reactions primarily within the Gastrointestinal Disorders (for oral forms) and Skin and Subcutaneous Tissue Disorders (for topical forms) System-Organ Classes.


Officially Documented Adverse Reactions

Adverse effects are categorized by frequency in official regulatory labeling:

  • Common Reactions: Gastrointestinal disturbances are the most frequently documented adverse effects associated with the oral suspension or tablets, including nausea, vomiting, diarrhea, and abdominal distress. Topical use may lead to local irritation, burning, or rash.
  • Rare Reactions: Less frequently, the product is associated with systemic hypersensitivity reactions (Immune System Disorders), which may include urticaria (hives), angioedema (swelling), and, very rarely, the severe reaction known as Stevens-Johnson syndrome.

Safety Constraints and Considerations

Official prescribing information includes specific limitations regarding the medicine’s use. Nystatin is contraindicated in individuals with a known history of hypersensitivity to the substance or any of its excipients. Furthermore, the drug is not indicated for the treatment of systemic mycoses (deep fungal infections), which reinforces its role strictly as a localized treatment.

Regulatory notes advise that if irritation or sensitization develops during therapy, treatment should be discontinued. Due to the product’s negligible absorption, specific warnings concerning hepatic or renal impairment are generally not present; however, caution is a standard consideration for use during pregnancy or lactation.

Overdose and Emergency Response

Overdose and When to Seek Help

The official overdose information for Nystatin emphasizes its negligible systemic absorption from the gut, which is the core reason that serious toxic effects or systemic poisoning are not reported in regulatory documents. Overdosage following ingestion is generally confined to the digestive tract.

Overdose Entity Official Regulatory Finding
Systemic Toxicity Not reported; no serious toxic effects documented.
Manifestations Limited to the gastrointestinal tract (GI).
Core Action Requires immediate contact with emergency medical services/Poison Control.

Documented Manifestations and Actions

The specific symptoms documented in prescribing information relate to localized GI upset, including nausea, vomiting, diarrhoea, and general gastrointestinal distress.

In any suspected overdose, immediate contact with medical professionals is mandatory. Regulatory agencies require individuals to:

  • Call the Poison Control Center immediately for specific guidance.
  • Seek Emergency Medical Attention if the individual has severe, non-specific symptoms such as having trouble breathing, a seizure, or if they have collapsed or can't be awakened.

Treatment is officially described as symptomatic and supportive, focused on managing GI symptoms. There is no specific antidote listed in the official labeling.

Therapeutic Uses of Statin

Quick Facts: Main Uses

  • May help manage high levels of LDL cholesterol (sometimes referred to as “bad” cholesterol) and total cholesterol.
  • May help reduce the risk of heart attack and stroke in people with existing cardiovascular disease.
  • Is an option for reducing the risk of heart events in individuals considered to be at high risk due to conditions such as diabetes.

Statins are a class of medication commonly prescribed to support lipid management. The primary function of this therapy is to help reduce the concentrations of low-density lipoprotein (LDL) cholesterol and total cholesterol in the bloodstream. Maintaining cholesterol at acceptable levels is important for preventing plaque formation in the arteries.

For individuals with a history of atherosclerotic cardiovascular disease, statin therapy may contribute to lowering the risk of a heart attack or a stroke. Furthermore, for those who are considered to have a high risk of developing cardiovascular events—including individuals with diabetes or other major risk factors—this medication may provide a potential means of prevention. The use of statins, in conjunction with diet and appropriate exercise, is generally advised by healthcare providers to support the overall management of hypercholesterolemia and reduce associated complications. Consult with a qualified professional to determine if this treatment may be suitable for your condition.

Regulatory References

  1. https://www.ncbi.nlm.nih.gov/books/NBK542212/

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Nystatin (Antifungal) — Official Regulatory Information

Note on Active Ingredient: The following eligibility criteria are for the antifungal agent Nystatin, which is pharmacologically distinct from the class of cholesterol-lowering drugs known as Statins.

Eligibility Scope

Category Official Regulatory Statement
Populations for whom use is allowed Adults and pediatric patients, including infants, for localized fungal infections.
Populations for whom use is not recommended Patients with infections diagnosed as systemic mycoses (prohibited due to the drug's poor systemic absorption).
Populations for whom use is contraindicated Patients with a known history of hypersensitivity or allergy to Nystatin or any excipient in the formulation.
Age-related eligibility rules Pediatric use is established from infancy; however, certain dosage forms (e.g., lozenges, tablets) are not recommended for children under five years old. Geriatric use is permitted with no notable regulatory difference.
Condition-specific eligibility rules Renal (kidney) and hepatic (liver) impairment do not impose restrictions for local administration.
Pregnancy and lactation eligibility status Generally permitted during pregnancy and lactation, based on the minimal systemic absorption of the drug.

Resulting Eligibility Structure

Official eligibility statements:

  • Use is contraindicated in patients with a history of hypersensitivity to the drug substance or any excipients.
  • The medicine is strictly contraindicated for the treatment of systemic fungal infections.
  • Eligibility is established across the full range of pediatric and adult age groups.

Connection to the overall eligibility profile: Regulatory documents define who can and cannot use this medicine based primarily on two factors: the risk of allergic reaction and the type of infection (must be localized). Because of the drug’s poor absorption into the bloodstream, eligibility is largely unrestricted by systemic conditions such as hepatic or renal impairment, or by physiological states like pregnancy and lactation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Nystatin is uniquely defined by its limited systemic absorption. As Nystatin is insignificantly absorbed into the bloodstream from the gastrointestinal tract, major regulatory documents do not list specific systemic drug-drug interactions involving metabolic enzymes (such as CYP) or drug transporters. This pharmacological fact is the key feature determining the minimal nature of pharmacokinetic interactions.

The documented interactions are instead localized and pharmacodynamic. Nystatin’s fungicidal mechanism may decrease the activity of other co-administered antifungal agents, such as Clotrimazole. This effect extends to living products, as Nystatin is officially stated to reduce the effects of yeast-based probiotics (like Saccharomyces boulardii) and may degrade certain cultured cellular products used for topical application.

Regulatory Focus Official Regulatory Statement
Contraindicated Combination Co-administration is formally contraindicated if there is a known history of hypersensitivity to Nystatin or any of its components.
Population Caution For patients with renal insufficiency, regulatory labels note that significant plasma concentrations of Nystatin may occasionally occur following oral therapy.

Mechanism of Action

How Statin Works: Mechanism of Action

Statins exert their primary action within the liver by acting as a competitive inhibitor of HMG-CoA Reductase, the critical enzyme controlling the rate-limiting step in the mevalonate pathway. This molecular interference immediately suppresses the intracellular synthesis of mevalonate and cholesterol.

The subsequent depletion of sterols activates the SREBP pathway transcriptional cascade, leading to a marked increase in the production and cell-surface display of LDL Receptors on hepatocytes. This cascade promotes the enhanced clearance and internalization of circulating Low-Density Lipoprotein (LDL) particles from the bloodstream.

Beyond lipid modulation, the mechanism also involves pleiotropic effects independent of cholesterol concentration. By suppressing the formation of isoprenoid intermediates, statins modulate intracellular signaling pathways (e.g., Rho/Rac GTPases) that influence the function of the blood vessel lining (endothelium) and alter chronic molecular inflammation within arterial walls.

Dosage and Administration Information

How to Use Statins

Statins are medications typically administered for the management of cholesterol levels and are primarily taken via the oral route in the form of tablets or capsules. This administration pattern allows the medication to be processed by the body to support cardiovascular health. The frequency and timing of the dose are designed to focus the medication's activity effectively.

Official Administration and Dosing

This medicine is typically prescribed for administration once a day, often at a consistent time to maintain steady levels in the bloodstream. For adults, the dose is determined based on individual health needs and lipid profiles. Specific dosage adjustments may be required for different age groups or those with specific underlying conditions to ensure the medication is used appropriately.

Procedural Instructions

Proper use of the medication requires following the specific guidance provided by a healthcare professional. For oral tablets, the dose should generally be swallowed with water. The duration of treatment is typically long-term rather than fixed, as the medication is intended to manage chronic conditions over time. Treatment should be continued consistently to support the ongoing management of cholesterol levels and to help reduce the risk of associated cardiovascular events.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Statin

This section outlines the structure of the clinical research that has evaluated statins, describing the types of studies conducted and what findings were observed, without offering individual advice or making claims about guaranteed outcomes.


Evidence for use in Preventing a First Heart Attack or Stroke (Primary Prevention)

Research has explored whether statins affect the measured frequency of a first major event, such as a heart attack or stroke, relying primarily on large, multi-year Randomized Controlled Trials (RCTs) and subsequent meta-analyses. These studies were applied in populations of asymptomatic adults considered high-risk based on risk scores. These trials carefully monitored two key types of outcomes: changes in lipid biomarkers like LDL cholesterol, and the actual occurrence of major cardiovascular events over time.

Findings from these RCTs and subsequent analyses of pooled data report measured differences in the frequency of cardiovascular events between the groups who received the statin and the groups who received placebo. Research papers describe changes measured in participants’ lipid profiles during the study period. Studies also monitored all-cause mortality, though the findings were mixed across different individual trials.


Evidence for use After a Heart Attack or Stroke (Secondary Prevention)

A substantial body of evidence exists from numerous large-scale RCTs and systematic reviews that examined statin use in research settings involving adults with established cardiovascular disease, such as prior heart attack or stroke. Studies focused on monitoring the recurrence of these cardiovascular events, the need for procedural interventions, and overall survival rates.

The studies reported observed differences in the measured rate of recurrent events between the statin-treated groups and control groups. Studies consistently report patterns of measured changes in the lipid biomarkers within these patient populations.

However, the structural research provides less insight into the progression of non-fatal conditions in the immediate years following the main trial duration. Also, direct comparative evidence is lacking for some individual statin agents at equivalent potencies.


What is Still Uncertain About Statin Research

Research provides context but also highlights areas where understanding is still incomplete. Comparative evidence on all specific outcomes across every available statin at equivalent doses is lacking. Data for certain special populations remain insufficient, and long-term effects are not fully established. Furthermore, evidence quality varies across studies, and findings were mixed for certain outcomes, such as all-cause mortality, across different trials. These research limitations reflect the specific conditions under which the studies were conducted.

Key Studies & References

  1. 2018 Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
  2. Cardiovascular disease: risk assessment and reduction, including lipid modification (NICE Guideline NG238)
  3. Cholesterol Treatment Trialists' (CTT) Collaboration: Efficacy and safety of statin therapy in older people: a meta-analysis of randomised controlled trials
  4. Heart Protection Study (HPS): MRC/BHF study of cholesterol lowering with simvastatin in 20,536 high-risk individuals

Frequently Asked Questions (FAQ)

Common questions about Statin (FAQ)

Q: What is the main purpose of taking a Statin?

Statins are indicated for lowering low-density lipoprotein (LDL or 'bad') cholesterol, lowering triglycerides, and for the prevention of cardiovascular disease. Regulatory documents define the official purpose as an adjunct to diet to help reduce elevated total cholesterol and LDL-C in adults.

Q: Is Statin used for anything other than lowering cholesterol?

Yes, official drug information indicates Statins are also prescribed to help lower high triglycerides and may increase high-density lipoprotein (HDL or 'good') cholesterol. Research indicates that Statins may also exert additional effects, known as pleiotropic effects, which can include influencing inflammation in the blood vessel walls.

Q: How long do most people need to take a Statin?

Official guidance related to high-risk conditions, such as established cardiovascular disease, indicates that Statin therapy is typically intended for long-term use. For severe conditions like familial hypercholesterolemia, therapy is generally an ongoing part of the treatment plan.

Q: Is it normal to feel tired when starting Statin?

Official reports from clinical trials and post-marketing surveillance note that unusual tiredness, fatigue, and weakness are reported side effects. Patients who experience new or persistent muscle-related symptoms, including fatigue, are advised in official counseling information to discuss them with their healthcare provider.

Q: Can Statin affect my energy levels?

Low energy levels or feeling easily tired are symptoms that may be associated with the drug's effects. Unexplained muscle weakness or being easily tired is a symptom that official patient counseling recommends discussing with a healthcare professional.

Q: Are all Statins the same, or are there different kinds?

Statins are a class of medications, meaning there are several different individual drug agents (such as Atorvastatin, Rosuvastatin, or Simvastatin). These agents can vary in their potency, characteristics, and specific FDA-approved indications.

Q: Is taking Statin a life-long commitment?

For individuals with established heart disease or a genetic condition that causes very high cholesterol, continuous Statin therapy is often indicated. The intent of long-term use is to help maintain cholesterol management and assist in reducing cardiovascular risk over time.

Q: What happens if someone stops taking Statin suddenly?

Official patient counseling information states that the medication should not be stopped without consulting a healthcare provider. Abrupt discontinuation of Statin therapy may potentially lead to a serious health problem.

Q: Can Statin cause muscle aches or pain?

Yes, muscle pain, tenderness, weakness (myopathy), and spasms are among the common and serious side effects reported. Official safety information recommends that patients discuss any unexplained or persistent muscle symptoms with a healthcare professional.

Q: Is memory loss or confusion linked to Statin use?

Post-marketing surveillance has included reports of cognitive impairment associated with Statin use. These effects include memory loss, forgetfulness, and confusion.

Q: Do Statins affect the liver?

Official product information states that Statins can cause abnormalities in liver enzymes, specifically persistent elevations in hepatic transaminases. While rare, there are reports of drug-induced liver injury; for this reason, routine monitoring of liver enzymes is often advised in official guidance.

Q: Are there certain foods or drinks that should be avoided while on Statin?

Official documentation for some Statins advises against consuming large amounts of grapefruit juice, defined as more than 1.2 liters daily. This interaction may increase the concentration of the medication in the blood, which could potentially raise the risk of side effects.

Q: Can Statin interact with common over-the-counter pain relievers?

Patients are generally advised in regulatory guidance to inform their doctor about all prescription and over-the-counter (OTC) medicines they are using. This comprehensive disclosure is necessary because potential interactions can exist with various medications.

Q: Is it safe to drink alcohol in moderation while taking Statin?

Official patient counseling information states that the consumption of alcohol should be limited while on Statin therapy. Drinking large amounts of alcohol may increase the risk of liver damage when combined with a Statin.

Q: What is the difference between LDL and HDL cholesterol in relation to Statin?

Statins are primarily known for their action on LDL cholesterol (the 'bad' cholesterol), promoting its clearance from the bloodstream. Official information also notes that Statins can modestly increase HDL cholesterol (the 'good' cholesterol) and lower triglycerides.

Q: Is Statin only for older people?

No. The FDA has approved the use of some Statins in pediatric patients. This is generally permitted for specific, approved forms of high cholesterol in younger patients.

Q: Can women take Statin safely?

Statins are generally prescribed for women, but official guidelines state that women of childbearing potential should use effective contraception. This is because the medication is contraindicated during pregnancy.

Q: What are the official guidelines regarding Statin use during pregnancy?

Official prescribing information states that Statins are contraindicated (should not be used) during pregnancy. This is due to the potential risk of harm to the fetus.

Q: Does Statin interact with grapefruit juice?

Yes, official guidance for some Statins recommends avoiding consumption of large quantities of grapefruit juice. This interaction may raise the drug concentration in the body, which could potentially lead to an increased risk of side effects.

Q: Is it common to have stomach issues like nausea or diarrhea when using Statin?

Gastrointestinal disturbances are frequently reported adverse effects associated with Statins. These include common issues such as diarrhea, nausea, constipation, and general stomach pain or upset.

Q: What do clinical trials suggest about the long-term use of Statins?

Clinical trials, including multi-year randomized controlled trials, have studied the long-term effectiveness of Statins. The results indicate that the drugs are generally tolerated and effective in reducing major cardiovascular event risk over sustained periods.

Q: Can Statin be taken alongside blood pressure medication?

While Statins can be taken with many common blood pressure medications, official warnings note that certain types of blood pressure drugs, such as some Calcium Channel Blockers, can interact and increase the risk of muscle problems.

Q: What are the major contraindications for Statin use mentioned in official documents?

According to official documentation, major contraindications include active liver disease (or unexplained, persistent elevations in liver enzymes), pregnancy, lactation, and having a known hypersensitivity to the medication.

Q: Do Statins interact with herbal supplements like St. John's wort?

Official guidance states that patients should inform their healthcare provider about all herbal products and supplements being taken, as potential drug interactions can affect Statin blood levels.

Q: Can Statin be prescribed for high triglycerides?

Yes, Statins are officially indicated as an adjunctive treatment for lowering elevated levels of serum triglycerides. This means they are used alongside dietary measures to manage high triglyceride levels.

Q: Why is my doctor checking my liver enzymes while I am on Statin?

Regulatory guidance advises checking liver enzymes (hepatic transaminases) before starting Statin therapy and periodically thereafter. This monitoring helps to observe for any signs of potential liver dysfunction or injury during the treatment course.

Q: What is the connection between Statins and type 2 diabetes risk?

Official prescribing information notes that Statins may cause increases in blood sugar levels (measured as HbA1c and fasting serum glucose). This may lead to an increased risk of developing Type 2 diabetes, especially in individuals already considered high-risk.

Q: Are there specific symptoms that warrant calling a doctor immediately while on Statin?

Official safety information lists symptoms that should be discussed promptly with a healthcare professional, such as unexplained muscle pain or weakness, dark-colored urine, and signs of liver injury (e.g., jaundice).

Q: Does my diet still matter if I am taking Statin?

Yes, official treatment guidelines and drug information emphasize that Statins are used as an adjunct to diet. Patients are typically advised in official guidance to follow a low-fat and low-cholesterol diet while on Statin therapy.

Q: Can Statins affect kidney function?

In rare but serious cases, severe muscle breakdown, called rhabdomyolysis, can occur and lead to acute renal (kidney) failure. Official guidance notes that caution is needed when prescribing Statins to patients with pre-existing kidney impairment.

Q: Do Statins interact with hormonal contraceptives?

Yes, official labeling notes that Statins can interact with hormonal contraceptives. This co-administration may increase the blood concentrations of the hormone components (such as norethindrone and ethinyl estradiol).

Q: What does 'contraindicated' mean for Statin?

'Contraindicated' refers to a medical condition or factor that provides a specific reason to not use a certain drug. For Statins, official documents list conditions like active liver disease or pregnancy as contraindications to the use of the medication.

Q: Are there any research updates about the effectiveness of Statins for different ethnic groups?

Official documents highlight that certain ethnic groups may have varying risk profiles for side effects. For example, it is noted that individuals of Asian descent may have an increased risk of muscle problems with specific Statins.

Q: Does Statin have any known interactions with vitamins?

Yes, one known interaction involves high doses of Niacin (Vitamin B3), which can increase the risk of muscle-related side effects. Patients are always advised to discuss the use of all vitamins and supplements with their provider.

Q: What is the evidence regarding Statins and their effect on inflammation markers?

Research and official documents describe the pleiotropic effects of Statins, which include modulating chronic molecular inflammation. These effects are independent of cholesterol reduction but contribute to the overall cardiovascular benefit.

Q: Can a high-fat diet override the effects of Statin?

Regulatory guidance emphasizes that Statin therapy is intended to be used in conjunction with a therapeutic diet. Maintaining a low-fat, low-cholesterol diet is considered necessary for achieving the full benefit of the medication.

Q: Why is Statin often prescribed with lifestyle changes?

Statins are indicated as an adjunct to diet and lifestyle modification, not as a standalone treatment. Official information indicates that the drug is intended to complement, not replace, these healthy changes, as both components work together to achieve the desired treatment goals for cardiovascular health.

Q: Is it required to take a different brand of Statin if one causes side effects?

Official information indicates that if a patient experiences muscle pain or other side effects with one Statin agent, switching to a different agent within the class may result in improvement or resolution of the symptoms.

Q: Do children or teenagers ever use Statin?

Yes, some Statins are specifically approved for use in pediatric patients. This includes children and adolescents, generally between the ages of 8 and 17, who have been diagnosed with certain specific forms of high cholesterol.

Q: Is there a known interaction between Statin and Warfarin?

Yes, Warfarin, which is a blood thinning medication (anticoagulant), is listed as a drug that interacts with certain Statins. Co-administration requires careful monitoring to ensure safety.

Q: Can taking Statin cause sleep problems or insomnia?

Insomnia, meaning difficulty falling or staying asleep, is an adverse effect that has been reported in association with Statin use, according to official adverse event reports.

Q: Can Statin cause skin reactions or rashes?

Official adverse reaction lists include general skin rashes and hives. In rare circumstances, Statins have also been associated with severe skin reactions, such as Stevens-Johnson syndrome.

Q: What does official guidance say about Statin use in patients with thyroid problems?

Official safety guidance indicates that patients who have uncontrolled hypothyroidism (an underactive thyroid gland) are at an increased risk of developing serious muscle problems when taking a Statin.

How should Statin be stored and disposed of?

How to Store and Dispose of Nystatin

Nystatin must be stored strictly according to regulatory requirements to maintain its stability. The medicine must be kept at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F). It is essential to protect the product from light and excessive moisture and ensure the container remains tightly closed .

Handling and Safety

Specific forms, such as the oral suspension, must not be frozen. Any unused medicine, including expired product, must be stored out of the sight and reach of children.

Disposal

Expired or unused Nystatin must be disposed of properly via an official drug take-back program. If a take-back program is unavailable, the medicine should be mixed with an undesirable substance (like coffee grounds or dirt) and sealed before being placed in household trash, following FDA guidelines. The product should not be flushed down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Statin found in:

A-Z Index: